GC Aesthetics® Announces the Launch of FixNip™: A Total Change in Breast Reconstruction | Business
DUBLIN–(BUSINESS WIRE)–May 17, 2022–
GC Aesthetics®, Inc. (GCA), a private medical technology company providing medical aesthetic solutions, announced the launch of an innovative Nipple Areola Complex (NAC) reconstructive implant: FixNip™ NRI.
This unequaled medical device is the answer to a well-known clinical need of thousands of women around the world. So far, various surgical techniques have been used in an attempt to reconstruct the nipple areola complex, none of which provide a long-term cosmetic solution.
GC Aesthetics® under an exclusive partnership agreement with FixNip LTD is proud to launch FixNip NRI in key European territories, while rollout in Latin America, Central Europe and Asia will be announced later this year.
“We are committed to providing safe options that set a newer, higher and more beneficial standard of care for women seeking total breast reconstruction. Such a breakthrough in technology will complement our suite of dedicated aesthetic healthcare solutions for FixNip from GC Aesthetics is a game changer for healthcare,” said Carlos Reis Pinto, CEO of GC Aesthetics®.
With this one-of-a-kind product, GC Aesthetics will spearhead expansion and growth in the breast reconstruction segment, elevating and improving upon current standards.
“The NAC reconstruction procedure should be considered an integral part of reconstructive breast surgery. It gives women an important psychological contribution and leads to greater well-being, a general sense of self and great satisfaction after being rebuilt. As the leader of the GCA Multicenter Safety and Efficacy Trial, I am very pleased with the results,” added Professor Dr. Michael Atlan, renowned French plastic surgeon.
The GC Aesthetics FixNip NRI is implanted with a minimally invasive procedure performed by a surgeon on average in 15 minutes. The result demonstrated high patient satisfaction with minimal patient downtime and an excellent safety profile.
“At GCA, we believe that total breast reconstruction is not just a choice, but a pathway for women to full recovery after mastectomy. We are extremely proud to add this product to our portfolio and what ‘it will mean to reconstructive and plastic surgeons and the lives of thousands of women.” Mentioned Fara Naomi Macías, CMO of GCA.
About GC Aesthetics
GC Aesthetics is a long-established global medical technology company that develops, manufactures and markets a full line of proprietary aesthetic products that empower patients to feel confident and secure in their personal life journey.
Throughout its 40 year history, GCA has been dedicated to advancing the science of medical aesthetics and providing high quality breast implants for breast augmentation and breast reconstructive surgery. We have sold over 3 million implants in 70 countries, and our products are backed by 10 years of published clinical data demonstrating compelling safety and clinical efficacy.
The company’s vertical integration strategy enables exceptional clinical, operational and commercial performance, which enables GCA to provide competitively differentiated products to surgeons and patients. Through a culture of continuous innovation and dedication to customer responsiveness, GCA has established itself as a leading provider of medical aesthetic solutions and the partner of choice for patients looking to improve their lives.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220517005134/en/
CONTACT: Fara Macias – CMO
+353 (0)1 293 3836
KEYWORD: IRELAND EUROPE
INDUSTRY KEYWORD: WOMEN MEDICAL SUPPLIES EQUIPMENT SURGERY HEALTH TECHNOLOGY CLINICAL TRIALS CONSUMER
SOURCE: GC Aesthetics
Copyright BusinessWire 2022.
PUBLISHED: 05/17/2022 10:15 AM/DISC: 05/17/2022 10:16 AM
Copyright BusinessWire 2022.